Breakout Stocks of Week 25
NASDAQ was up last week (week 24) by 3.24% ending at 17,688.88 points after gaining 555.76 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Arbor Realty Trust NYSE:ABR. This stock has had a buy signal since Jun 12, 2024 when the price was $13.68 and is so far up 0.0731% to $13.69. Some other companies are on our watchlist to, among these are Goldman Sachs BDC Inc NYSE:GSBD Amedisys Inc NASDAQ:AMED Hershey Company (The) NYSE:HSY and Douglas Emmett Inc NYSE:DEI which all got a breakout pattern emerging.
| Date | Company | Price | Week 25 |
|---|---|---|---|
| Arbor Realty Trust | $13.69 | $14.12 | 3.14% |
| Goldman Sachs Bdc Inc | $15.26 | $15.63 | 2.42% |
| Amedisys Inc | $91.82 | $91.77 | -0.0545% |
| Hershey Company (the) | $186.98 | $182.09 | -2.62% |
| Douglas Emmett Inc | $13.30 | $13.39 | 0.677% |
The Arbor Realty Trust stock price fell by -1.01% on the last day (Friday, 14th Jun 2024) from $13.83 to $13.69. During the last trading day the stock fluctuated 1.54% from a day low at $13.60 to a day high of $13.81. The price has fallen in 6 of the last 10 days but is still up by 0.07% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 1 million shares were bought and sold for approximately $15.74 million.
On Jun 20, 2024, it was reported that Wedbush gave ABR a "Market Outperform" grade with a "hold" action.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Arbor Realty Trust stock to perform well in the short-term.
About Arbor Realty Trust:
Arbor Realty Trust, Inc. invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States. The company operates in two segments, Structured Business and Agency Business. It primarily invests in bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related joint ventures, real estate-related notes, and various mortgage-related securities. The company offers bridge financing products to borrowers who seek short-term capital to be used in an acquisition of property; financing by making preferred equity investments in entities that directly or indirectly own real property; mezzanine financing in the form of loans that are subordinate to a conventional first mortgage loan and senior to the borrower's equity in a transaction; junior participation financing in the form of a junior participating interest in the senior debt; and financing products to borrowers who are looking to acquire conventional, workforce, and affordable single-family housing. Further, it underwrites, originates, sells, and services multifamily mortgage loans through conduit/commercial mortgage-backed securities programs. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Arbor Realty Trust, Inc. was incorporated in 2003 and is headquartered in Uniondale, New York.
The Goldman Sachs BDC Inc stock price gained 0.329% on the last trading day (Friday, 14th Jun 2024), rising from $15.21 to $15.26. During the last trading day the stock fluctuated 0.86% from a day low at $15.13 to a day high of $15.26. The price has been going up and down for this period, and there has been a -0.78% loss for the last 2 weeks. Volume fell on the last day by -31 thousand shares and in total, 509 thousand shares were bought and sold for approximately $7.77 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
On May 29, 2024, it was reported that Wells Fargo gave GSBD a "Underweight" grade with a "downgrade" action.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Goldman Sachs BDC Inc:
Goldman Sachs BDC, Inc. is a business development company specializing in middle market and mezzanine investment in private companies. It seeks to make capital appreciation through direct originations of secured debt, senior secured debt, junior secured debt, including first lien, first lien/last-out unitranche and second lien debt, unsecured debt, including mezzanine debt and, to a lesser extent, investments in equities. The fund primarily invests in United States. It seeks to invest between $10 million and $75 million in companies with EBITDA between $5 million and $75 million annually.
The Amedisys Inc stock price gained 0.153% on the last trading day (Friday, 14th Jun 2024), rising from $91.68 to $91.82. During the last trading day the stock fluctuated 0.96% from a day low at $91.00 to a day high of $91.87. The price has risen in 6 of the last 10 days and is up by 0.74% over the past 2 weeks. Volume fell on the last day by -59 thousand shares and in total, 250 thousand shares were bought and sold for approximately $22.99 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
On Sep 14, 2023, it was reported that Cantor Fitzgerald gave AMED a "Neutral" grade with a "hold" action.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Amedisys Inc stock to perform well in the short-term period.
About Amedisys Inc:
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
The Hershey Company (The) stock price gained 0.749% on the last trading day (Friday, 14th Jun 2024), rising from $185.59 to $186.98. During the last trading day the stock fluctuated 2.03% from a day low at $185.30 to a day high of $189.06. The price has fallen in 8 of the last 10 days and is down by -5.48% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 273 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $213.74 million.
On May 05, 2024, it was reported that Citigroup gave HSY a "Neutral" grade with a "hold" action.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Hershey Company (The):
The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally. The company operates through three segments: North America Confectionery, North America Salty Snacks, and International. It offers chocolate and non-chocolate confectionery products; gum and mint refreshment products, including mints, chewing gums, and bubble gums; pantry items, such as baking ingredients, toppings, beverages, and sundae syrups; and snack items comprising spreads, meat snacks, bars and snack bites, mixes, popcorn, and protein bars. The company provides its products primarily under the Hershey's, Reese's, Kisses, Jolly Rancher, Almond Joy, Brookside, barkTHINS, Cadbury, Good & Plenty, Heath, Kit Kat, Payday, Rolo, Twizzlers, Whoppers, York, Ice Breakers, Breath Savers, Bubble Yum, Lily's, SkinnyPop, Pirates Booty, Paqui, Dot's Homestyle Pretzels, and ONE Bar brands, as well as under the Pelon Pelo Rico, IO-IO, and Sofit brands. It markets and sells its products to wholesale distributors, chain grocery stores, mass merchandisers, chain drug stores, vending companies, wholesale clubs, convenience stores, dollar stores, concessionaires, and department stores. The company was founded in 1894 and is headquartered in Hershey, Pennsylvania.
The Douglas Emmett Inc stock price fell by -0.150% on the last day (Friday, 14th Jun 2024) from $13.32 to $13.30. During the last trading day the stock fluctuated 2.29% from a day low at $13.10 to a day high of $13.40. The price has fallen in 8 of the last 10 days and is down by -4.66% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -179 thousand shares and in total, 1 million shares were bought and sold for approximately $15.31 million.
On Jun 11, 2024, it was reported that Citigroup gave DEI a "Neutral" grade with a "hold" action.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Douglas Emmett Inc stock to perform well in the short-term.
About Douglas Emmett Inc:
Douglas Emmett, Inc. (DEI) is a fully integrated, self-administered and self-managed real estate investment trust (REIT), and one of the largest owners and operators of high-quality office and multifamily properties located in the premier coastal submarkets of Los Angeles and Honolulu. Douglas Emmett focuses on owning and acquiring a substantial share of top-tier office properties and premier multifamily communities in neighborhoods that possess significant supply constraints, high-end executive housing and key lifestyle amenities.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
